Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Jun 2015 03:13 PM
RNS
Oxford BioMedica plc Director's Share Purchase
09 Jun 2015 02:56 PM
RNS
Director/PDMR Shareholding
01 Jun 2015 07:00 AM
RNS
Total Voting Rights
22 May 2015 07:00 AM
RNS
Director/PDMR Shareholding
20 May 2015 07:00 AM
RNS
Director/PDMR Shareholding
08 May 2015 07:00 AM
RNS
Deferred Bonus Plan
07 May 2015 01:02 PM
RNS
Result of AGM
07 May 2015 12:37 PM
RNS
Appointment of Non-Executive Director
07 May 2015 07:00 AM
RNS
Interim Management Statement
05 May 2015 07:02 AM
RNS
Presentation of RetinoStat® results
05 May 2015 07:02 AM
RNS
Summary of ProSavin® data
01 May 2015 07:00 AM
RNS
Secures $50 million loan with Oberland Capital
01 May 2015 07:00 AM
RNS
Total Voting Rights
02 Apr 2015 03:40 PM
RNS
2014 Annual Report and Accounts & AGM Notification
01 Apr 2015 04:43 PM
RNS
Holding(s) in Company
01 Apr 2015 12:27 PM
RNS
Oxford BioMedica Total Voting Rights
20 Mar 2015 07:00 AM
RNS
OXB Present at 3rd Annual Regen Med Investor Day
16 Mar 2015 08:59 AM
RNS
Oxford BioMedica plc Director's Share Purchase
13 Mar 2015 07:00 AM
RNS
Preliminary Results
06 Mar 2015 07:00 AM
RNS
Notice of Preliminary Results
05 Mar 2015 09:02 AM
RNS
Announces Presentation at Annual ROTH Conference
03 Mar 2015 07:00 AM
RNS
Credit Suisse's Global Healthcare Conference
03 Mar 2015 07:00 AM
RNS
Total Voting Rights
23 Feb 2015 03:36 PM
RNS
Chief Secretary to the Treasury visits OXB
16 Feb 2015 11:41 AM
RNS
Change of Registered Address
30 Jan 2015 10:47 AM
RNS
Total Voting Rights
28 Jan 2015 04:40 PM
RNS
Second Price Monitoring Extn
28 Jan 2015 04:35 PM
RNS
Price Monitoring Extension
31 Dec 2014 07:00 AM
RNS
BLOCK LISTING RETURN
31 Dec 2014 07:00 AM
RNS
Total Voting Rights
18 Dec 2014 02:45 PM
RNS
Director's Share Purchase.
18 Dec 2014 07:00 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES.
16 Dec 2014 03:50 PM
RNS
Director PDMR Shareholding
16 Dec 2014 03:50 PM
RNS
Notification Of Major Interest In Shares
01 Dec 2014 07:00 AM
RNS
Oxford BioMedica plc Director's Share Purchase
28 Nov 2014 07:00 AM
RNS
Total Voting Rights
26 Nov 2014 07:00 AM
RNS
Director Dealings
03 Nov 2014 07:00 AM
RNS
Interim Management Statement
31 Oct 2014 07:00 AM
RNS
Total Voting Rights
17 Oct 2014 09:27 AM
RNS
Director's Interest in Share Options
17 Oct 2014 09:10 AM
RNS
Holding(s) in Company
16 Oct 2014 04:52 PM
RNS
Directorate Change
15 Oct 2014 05:05 PM
RNS
Holding(s) in Company
14 Oct 2014 07:00 AM
RNS
Oxford BioMedica plc Director's Share Purchase
13 Oct 2014 07:00 AM
RNS
Oxford BioMedica Acquires Windrush Court Office
10 Oct 2014 07:41 AM
RNS
Additional Listing
10 Oct 2014 07:00 AM
RNS
Second major agreement with Novartis
28 Aug 2014 07:00 AM
RNS
Half Yearly Report
15 Aug 2014 07:00 AM
RNS
Paul Blake Appointed as Chief Development Officer
07 Aug 2014 07:00 AM
RNS
Notice of Results

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100